McCloskey Molly C, Ahmad S Danial, Widom Louis P, Kasap Pelin, Gastfriend Benjamin D, Shusta Eric V, Palecek Sean P, Engelhardt Britta, Gaborski Thomas R, Flax Jonathan, Waugh Richard E, McGrath James L
Department of Biomedical Engineering, University of Rochester, Rochester NY, USA.
Department of Biomedical Engineering, Rochester Institute of Technology, Rochester NY, USA.
Biomater Res. 2024 Oct 3;28:0081. doi: 10.34133/bmr.0081. eCollection 2024.
Sepsis is the most lethal and expensive condition treated in intensive care units. Sepsis survivors frequently suffer long-term cognitive impairment, which has been linked to the breakdown of the blood-brain barrier (BBB) during a sepsis-associated "cytokine storm". Because animal models poorly recapitulate sepsis pathophysiology, human models are needed to understand sepsis-associated brain injury and to develop novel therapeutic strategies. With the concurrent emergence of tissue chip technologies and the maturation of protocols for human induced pluripotent stem cell (hiPSC), we can now develop advanced in vitro models of the human BBB and immune system to understand the relationship between systemic inflammation and brain injury. Here, we present a BBB model of the primary barrier developed on the μSiM (microphysiological system enabled by an ultrathin silicon nanomembrane) tissue chip platform. The model features isogenically matched hiPSC-derived extended endothelial culture method brain microvascular endothelial cell-like cells (EECM-BMEC-like cells) and brain pericyte-like cells (BPLCs) in a back-to-back coculture separated by the ultrathin (100 nm) membrane. Both endothelial monocultures and cocultures with pericytes responded to sepsis-like stimuli, with increased small-molecule permeability, although no differences were detected between culture conditions. Conversely, BPLC coculture reduced the number of neutrophils that crossed the EECM-BMEC-like cell monolayer under sepsis-like stimulation. Interestingly, this barrier protection was not seen when the stimulus originated from the tissue side. Our studies are consistent with the reported role for pericytes in regulating leukocyte trafficking during sepsis but indicate that EECM-BMEC-like cells alone are sufficient to maintain the restrictive small-molecule permeability of the BBB.
脓毒症是重症监护病房中治疗的最致命且最昂贵的病症。脓毒症幸存者经常遭受长期认知障碍,这与脓毒症相关的“细胞因子风暴”期间血脑屏障(BBB)的破坏有关。由于动物模型难以重现脓毒症的病理生理学,因此需要人类模型来了解脓毒症相关的脑损伤并开发新的治疗策略。随着组织芯片技术的同时出现以及人类诱导多能干细胞(hiPSC)方案的成熟,我们现在可以开发人类血脑屏障和免疫系统的先进体外模型,以了解全身炎症与脑损伤之间的关系。在这里,我们展示了一种在μSiM(由超薄硅纳米膜支持的微生理系统)组织芯片平台上开发的主要屏障的血脑屏障模型。该模型的特点是在由超薄(100纳米)膜隔开的背靠背共培养中,有基因匹配的hiPSC衍生的扩展内皮培养法脑微血管内皮细胞样细胞(EECM - BMEC样细胞)和脑周细胞样细胞(BPLCs)。内皮细胞单培养和与周细胞的共培养对类脓毒症刺激均有反应,小分子通透性增加,尽管在培养条件之间未检测到差异。相反,BPLC共培养减少了在类脓毒症刺激下穿过EECM - BMEC样细胞单层的中性粒细胞数量。有趣的是,当刺激源自组织侧时,未观察到这种屏障保护作用。我们的研究与报道的周细胞在脓毒症期间调节白细胞运输中的作用一致,但表明仅EECM - BMEC样细胞就足以维持血脑屏障对小分子的限制性通透性。